AB
Healthcare & Life Sciences
Aeglea BioTherapeutics
United States
Aeglea BioTherapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Aeglea BioTherapeutics
Aeglea BioTherapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Aeglea BioTherapeutics develops engineered human enzymes as novel therapies for rare genetic and metabolic diseases.
Explore Aeglea BioTherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.